home.social

#traumaticbraininjury — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #traumaticbraininjury, aggregated by home.social.

  1. DATE: October 9, 2026 at 03:07AM
    SOURCE: SOCIALPSYCHOLOGY.ORG

    TITLE: Drug Target Could Block Brain Inflammation Linked to Alzheimer's

    URL: socialpsychology.org/client/re

    Source: Science Daily - Top Health

    Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery, published in the journal Brain, could help researchers repurpose existing drugs to treat conditions that include traumatic brain injury, Alzheimer's disease, Parkinson's disease, depression, and schizophrenia.

    URL: socialpsychology.org/client/re

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #BrainInflammation #P2X7 receptor #AlzheimersResearch #NeurologicalDisorders #BrainInflammationTreatment #RepurposedDrugs #TraumaticBrainInjury #ParkinsonsDisease #Schizophrenia #DepressionTreatment

  2. Curtin University study identifies risk factors for prolonged concussion symptoms

    A new Curtin University study has found almost half of people who experience a concussion still experience problems…
    #NewsBeep #News #Health #Brain #CA #Canada #concussion #Fatigue #MedicalResearch #Mentalhealth #research #Sleep #traumaticbraininjury
    newsbeep.com/ca/924118/

  3. DATE: October 7, 2026 at 08:13AM
    SOURCE: SCIENCE DAILY PSYCHIATIRY FEED

    TITLE: Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

    URL: sciencedaily.com/releases/2026

    Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #P2X7 #braininflammation #Alzheimers #Parkinsons #neurodegenerative #drugrepurposing #neurologicaldisorders #psychiatricdisorders #traumaticbraininjury #inflammationresearch

  4. DATE: October 7, 2026 at 08:13AM
    SOURCE: SCIENCE DAILY PSYCHOLOGY FEED

    TITLE: Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

    URL: sciencedaily.com/releases/2026

    Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #P2X7 #BrainInflammation #Alzheimers #Parkinsons #Neuroinflammation #NeurologicalDisorders #MentalHealth #TraumaticBrainInjury #DrugRepurposing #Neuroscience

  5. DATE: October 7, 2026 at 08:13AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

    URL: sciencedaily.com/releases/2026

    Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #P2X7 #neuroinflammation #Alzheimers #Parkinsons #AlzheimersAndDementia #traumaticbraininjury #neurologicaldisorders #psychiatricdisorders #drugrepurposing #brainhealth

Share on Mastodon

Enter the server where you have an account.